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432(9 of 11) and 86% (6 of 7) of ﬁbroatheromatous and ﬁbrous plaques
compared with histopathology. Two cases were classiﬁed as ﬁbrous
by OCT but ﬁbroatheromatous by histopathology, and 1 case was
classiﬁed as ﬁbroatheromatous by OCT but ﬁbrocalciﬁc by
histopathology.
Macrophages appeared brown with low intensity by ﬂuorescence
and pink to pale white by bright-ﬁeld (Fig. 1f). Elastin appeared as
bright green streaks by ﬂuorescence and pink to pale white by
bright-ﬁeld (Fig. 1g). Cryoimaging green ﬂuorescence was the best
individual marker of inﬂammation at 0% (odds ratio: 0.93; p <
0.05) and 10% (odds ratio: 0.95; p < 0.05) macrophage, with areas
under the curve of 0.958 (95% conﬁdence interval: 0.869 to 1.000;
p < 0.001) and 0.790 (95% conﬁdence interval: 0.516 to 1.000;
p < 0.05), respectively. Using green ﬂuorescence intensity <60 as
positive for inﬂammation (i.e., >0% macrophage), sensitivity was
91.7% (p ¼ 0.003), speciﬁcity 100% (p ¼ 0.016), positive predictive
value 100% (p < 0.001), negative predictive value 85.7% (p ¼ 0.06),
and accuracy 94.4% (p < 0.001).
We demonstrate that less cryoimaging ﬂuorescence correlates
with greater density of macrophage and less elastin. These properties
are consistent with studies using different excitation and emission
wavelengths (4). Although this trial was small, a volumetric
approach for comparing optical coherence tomographic images with
cryoimaging and histopathology was successfully introduced. Early
data yielded sensitivities of OCT within range reported in previous
research. Errors in screening are typically related to misidentiﬁcation
of lipid versus ﬁbrous and calciﬁed plaques (5). Cryoimaging is a
promising adjuvant for plaque characterization on the basis of high
sensitivity and speciﬁcity for these constituents.
Clinical applications of volumetric tissue characterization by cry-
oimaging are numerous. Volume-rendering techniques are being
developed to improve 3-dimensional coregistration between in vivo
modalities and cryoimaging. Tissue volumes may be segmented and
compared quantitatively to obtain more accurate results than by his-
topathology alone. Segmentation of elastin and inﬂammation during
volume renderings may be analyzed via ﬁnite element analysis to
understand effects of plaque deformation on genuine vessel archi-
tecture. Coupling to in vivo imaging modalities provides potential for
understanding the real-time effects of therapeutic intervention (i.e.,
stent deployment) on ﬁbrous cap stress. Fluorescence tagging before
imaging allows volumetric quantiﬁcation of desired cells or proteins.
In conclusion, this pilot study demonstrates that cryoimaging is
capable of detecting ﬁbrous cap inﬂammation with high sensitivity
and speciﬁcity. Potential for macrophage quantiﬁcation was
demonstrated at 2 thresholds. Cryoimaging is a promising adjunct
to histopathology for studies aiming to validate OCT for plaque
characterization.
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In the Footsteps of Virchow
We read with interest the report on “Fat Deposition in Dilated
Cardiomyopathy Assessed by CMR” by Lu et al. (1), because it
describes a phenomenon already observed by Rudolph Virchow in
1858. In his book on cellular pathology, he devotes 2 full chapters to
fatty atrophy of the heart (2). In lecture 16, he describes the fatty
degeneration of the muscular substance of the heart in its different
stages. Here we quote the text verbatim:
You will observe that, even with the naked eye, certain
changes can be recognized in the heart, namely a discol-
oration of its whole substance (which no longer presents
the red hue of muscle, but wears a pale yellow tint), and
besides peculiar spots on the papillary muscles. If you
examine these more closely, you will perceive, in the di-
rection of the primitive fasciculi, short, yellowish streaks
which communicate so as almost to present a plexiform
arrangement, and pervade the substance of the papillary
muscles, whilst they offer a striking contrast to the reddish
colour of proper muscular substance. This is the perfect
form of genuine fatty metamorphosis of the real muscular
substance of the heart, which differs most essentially from
obesity of the heart, in which this organ becomes extremely
fat and adipose tissue here and there so inﬁltrates its walls,
that scarcely any muscle is to be perceived.
Unlike Virchow, the investigators of the present study have not
been able to distinguish between intramyocellular and extra-
myocellular fat. The investigators also elected to omit the metabolic
proﬁles of their patients. This might be of importance because we
identiﬁed a subgroup of heart failure patients with severe metabolic
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433dysregulation featuring intramyocardial triglyceride overload and
gene expression that are associated with contractile dysfunction (3).
In the end, after more than 150 years we are all still walking in
Virchow’s footsteps.
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We thank Drs. Taegtmeyer and Lam for their interest in our recent
publication (1) and for the opportunity to discuss their comments.
It is entirely true that fat deposition is part of the normal phys-
iological process of involution. It occurs with aging just as Rudolph
Virchow described in 1858 (2). However, the subjects selected for
our study were patients with idiopathic dilated cardiomyopathy. We
tried to investigate the prevalence of fat deposition in a particular
group of subjects and its effects on cardiac functions.
With respect to the intramyocellular or extramyocellular fat, it
was reported that intramyocellular lipid could be detected by mag-
netic resonance spectroscopy (MRS) in the musculoskeletal system
(3). Depending on the observed nucleus, MRS provides information
on the chemical composition of the tissue. It allows the observation
of high-energy phosphates (31P-MRS), glycogen (13C-MRS), or
intramyocellular lipids (1H-MRS) based on the nomenclature in
muscle spectra recorded in vivo (the CH2 signal at 1.28 parts per
million is usually attributed to intramyocellular lipids and the
shifting CH2 resonances as extramyocellular lipids). However, it is
at the cost of a lower spatial resolution by using MRS investigating
the chemical composition of the tissue. It is still a challenge to
distinguish intramyocellular lipid from extramyocellular lipid with
current spatial resolution provided by cardiac magnetic resonance.Sharma et al. (4) found that intramyocardial triglyceride overload
was associated with cardiac contractile dysfunction. Unfortunately,
they did not provide medical images or pathological specimen
photographs demonstrating fat deposition in the human heart.
Maybe such intramyocellular lipid was too small to be seen by the
naked eye. Because there was a case of heart transplantation in our
study, which was conﬁrmed by pathology, we consider that the fat
signal detected by cardiac magnetic resonance in this study is very
probably extramyocellular fat instead of intramyocellular fat.
With regard to the “omitted patients’ metabolic proﬁles,” we
really did not intend to. Because patients in this study had non-
ischemic cardiomyopathy, the majority of venous blood lipid results
were within normal limits. We did not collect patients’ metabolic
data and perform further statistical analysis. It may be a limitation of
our paper according to the ﬁndings by Sharma et al. (4). Anyway,
their comments are interesting and point in an important direction
to pay attention to the effects of lipid metabolism on cardiac
function.
After more than 150 years, we are all still following Dr. Virchow’s
footsteps. However, we have seen farther by standing on his
shoulders.
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